Live Breaking News & Updates on Eli lilly and co

Stay informed with the latest breaking news from Eli lilly and co on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Eli lilly and co and stay connected to the pulse of your community

Eli Lilly, Apple are among 12 portfolio stocks reporting in week ahead

All three major U.S. stock indexes rose this week. Earnings are once again poised drive the week ahead.

United-states , China , Norway , Canada , Brookfield , Nova-scotia , American , Norwegian , Canadian , Jim-cramer , Estee-lauder , Novo-nordisk

Jim Cramer's favorite investment themes and 3 stocks he likes now

Jim Cramer and Jeff Marks offered their thoughts on Wells Fargo, secular investment themes and more during the April Monthly Meeting.

Minnesota , United-states , Texas , Philadelphia , Pennsylvania , China , America , Chinese , Gordon-jim-cramer , Anthony-jim-cramer , Estee-lauder , Eli-lilly

Jim Cramer's rapid-fire update on all 33 Investing Club stocks

During the Investing Club's Monthly Meeting on Wednesday, Jim Cramer offered his updated thinking on the stocks in the portfolio.

Canada , Marshall-islands , Macao , Macau-general- , Macau , China , Marshalls , Chinese , Canadian , Laxman-narasimhan , Nelson-peltz , Tom-jorden

Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending

A recent survey conducted by Morgan Stanley reveals that the use of GLP-1 drugs, popular for weight loss and diabetes, is affecting consumers’ spending…

Novo-nordisk , Morgan-stanley , Eli-lilly-and-co , News , Ggregator , Reaking-news , Uration , Edia ,

Weight loss drug patients spend less on restaurants, takeout: survey

The findings add to concerns that GLP-1s could take a bite out of the bottom lines of some of the biggest restaurant companies and packaged food makers.

Morgan-stanley , Business , Biotechnology , Biotech-and-pharmaceuticals , Pharmaceuticals , Health-care-industry , Novo-nordiska-s , Eli-lilly-and-co , Cava-group-inc , Chipotle-mexican-grill-inc , Sweetgreen-inc